Fitxers

649160.pdf (1.19 MB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2014-09-12

Llicència de publicació

cc-by (c) Williams, James P. et al., 2014
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/117328

HIV-1 DNA predicts disease progression and post-treatment virological control

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.7554/eLife.03821

Resum

In HIV-1 infection, a population of latently infected cells facilitates viral persistence despite antiretroviral therapy (ART). With the aim of identifying individuals in whom ART might induce a period of viraemic control on stopping therapy, we hypothesised that quantification of the pool of latently infected cells in primary HIV-1 infection (PHI) would predict clinical progression and viral replication following ART. We measured HIV-1 DNA in a highly characterised randomised population of individuals with PHI. We explored associations between HIV-1 DNA and immunological and virological markers of clinical progression, including viral rebound in those interrupting therapy. In multivariable analyses, HIV-1 DNA was more predictive of disease progression than plasma viral load and, at treatment interruption, predicted time to plasma virus rebound. HIV-1 DNA may help identify individuals who could safely interrupt ART in future HIV-1 eradication trials.

Matèries

VIH (Virus), Antiretrovirals, Malalties infeccioses, Assaigs clínics

Matèries (anglès)

HIV (Viruses), Antiretroviral agents, Communicable diseases, Clinical trials

Citació

Col·leccions

Articles publicats en revistes (Medicina)

Citació

WILLIAMS, James P., et al. HIV-1 DNA predicts disease progression and post-treatment virological control. eLife. 2014. Vol. 3, num. e03821. ISSN 2050-084X. [consulted: 29 of May of 2026]. Available at: https://hdl.handle.net/2445/117328

Exportar metadades

JSON - METS

Compartir registre